Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

5.675 +0.105 (+1.89%)
Streaming Delayed Price Updated: 2:45 PM EDT, Mar 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,500
Open 5.400
Bid (Size) 5.600 (700)
Ask (Size) 5.670 (100)
Prev. Close 5.570
Today's Range 5.360 - 5.910
52wk Range 0.4621 - 10.81
Shares Outstanding 145,148,593
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
SciSparc Announces 1-for-9 Reverse Share Split
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
From SciSparc Ltd
Via GlobeNewswire

Performance

YTD
+305.4%
+305.4%
1 Month
+729.7%
+729.7%
3 Month
+182.3%
+182.3%
6 Month
+154.5%
+154.5%
1 Year
-32.4%
-32.4%

More News

Read More
News headline image
SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization
From SciSparc Ltd
Via GlobeNewswire
Which stocks are moving after the closing bell on Wednesday? ↗
Via Chartmill
These stocks are gapping in today's session ↗
Via Chartmill
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
News headline image
SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
From SciSparc Ltd
Via GlobeNewswire
News headline image
Get insights into the top gainers and losers of Friday's after-hours session. ↗
Via Chartmill
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
From SciSparc Ltd
Via GlobeNewswire
News headline image
Traders are paying attention to the gapping stocks in Wednesday's session. ↗
Via Chartmill
News headline image
Wednesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
SciSparc Stock Soars Pre-Market After Snapping Up Patents For Next-Gen Endoscopy Tech ↗
Via Stocktwits
Topics Intellectual Property
News headline image
SciSparc to Acquire Treasury of Patents for Innovative Medical Endoscopy Systems
From SciSparc Ltd
Via GlobeNewswire
News headline image
These stocks that are showing activity before the opening bell on Tuesday. ↗
Via Chartmill
News headline image
SciSparc: Neurothera Labs Announces Israeli Patent Application in Collaboration with Clearmind Medicine for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
From SciSparc Ltd
Via GlobeNewswire
News headline image
Clearmind Medicine Files Israeli Patent for Novel Non-Hallucinogenic Neuroplastogen Treatment for Depression
From Clearmind Medicine Inc.
Via GlobeNewswire
News headline image
SciSparc Announces Closing of the Acquisition of a Publicly Traded Company on the TSXV to which it transferred its Advanced Clinical Stage Pharmaceutical Portfolio
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Announces Closing of the Sale to N2OFF of Majority-Owned Subsidiary MitoCareX, Advancing Drug Discovery for Resistant Cancers Including Pancreatic and Non-Small Cell Lung Cancer
From SciSparc Ltd
Via GlobeNewswire
News headline image
SciSparc Targets Quantum-Powered 3D Protein Modeling Technology to Revolutionize AI Drug Discovery
From SciSparc Ltd
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Clearmind Medicine Announces Publication of U.S. Patent Application Targeting Binge Behavior Disorders
From Clearmind Medicine Inc.
Via GlobeNewswire

Frequently Asked Questions

Is SciSparc Ltd. - Ordinary Shares publicly traded?
Yes, SciSparc Ltd. - Ordinary Shares is publicly traded.
What exchange does SciSparc Ltd. - Ordinary Shares trade on?
SciSparc Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for SciSparc Ltd. - Ordinary Shares?
The ticker symbol for SciSparc Ltd. - Ordinary Shares is SPRC on the Nasdaq Stock Market
What is the current price of SciSparc Ltd. - Ordinary Shares?
The current price of SciSparc Ltd. - Ordinary Shares is 5.675
When was SciSparc Ltd. - Ordinary Shares last traded?
The last trade of SciSparc Ltd. - Ordinary Shares was at 03/09/26 02:45 PM ET
What is the market capitalization of SciSparc Ltd. - Ordinary Shares?
The market capitalization of SciSparc Ltd. - Ordinary Shares is 823.72M
How many shares of SciSparc Ltd. - Ordinary Shares are outstanding?
SciSparc Ltd. - Ordinary Shares has 824M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.